SIA
GSK icon

Stancorp Investment Advisers’s GSK GSK Stock Holding History

Stancorp Investment Advisers’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$663K Sell
11,494
-7,630
-40% -$437K 0.31% 88
2014
Q4 		$1.02M Buy
+19,124
New +$1.07M 0.47% 63

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stancorp Investment Advisers's GSK Position: Q1 2015 in Review

Stancorp Investment Advisers reduced its GSK (GSK) stake by 40% in Q1 2015, selling an estimated $437K and leaving 11,494 shares worth $663K. The position accounts for 0.31% of the portfolio, ranked #88.

Stancorp Investment Advisers first reported a position in GSK in Q4 2014 and has held it in 2 quarters since. The position peaked at $1.02M in Q4 2014. 740 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

  • Stancorp Investment Advisers held 11,494 shares of GSK worth $663K as of Q1 2015.
  • Stancorp Investment Advisers sold 7,630 GSK shares in Q1 2015, an estimated $437K.
  • GSK made up 0.31% of Stancorp Investment Advisers's portfolio in Q1 2015, its #88 holding.
  • Stancorp Investment Advisers first reported a position in GSK in Q4 2014 and has held it in 2 quarters since.
  • Stancorp Investment Advisers's GSK position peaked at $1.02M in Q4 2014.
  • 740 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.